Ledger.Open graph →
SEC Form D · filed October 20, 2023

Interius BioTherapeutics, Inc

Offering
$21.5M
Sold
$21.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Philadelphia, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Craig B. Prenter · Burnaby, British Columbia, CanadaDirectorNelson C. Chu · Chevy Chase, MDExec · DirectorTomas R. Kiselak · Philadelphia, PADirectorPhilip R. Johnson · Philadelphia, PAExec · DirectorLeon R. Moulder, Jr · Philadelphia, PADirectorBrandon E. Fitch · New York, NYExecBenjamin R. Lund · Philadelphia, PADirectorLeon R. Moulder, Jr · Philadelphia, PADirectorPhilip R. Johnson · Philadelphia, PAExec · DirectorMichael Dale · West Newton, MAExecCourtney A. Oliver · Westport, CTDirectorPeter A. Sherlock · Westport, CTDirectorAndy Wang · San Francisco, CADirectorDora R. Mitchell · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗